Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.

Polireddy K, Dong R, McDonald PR, Wang T, Luke B, Chen P, Broward M, Roy A, Chen Q.

PLoS One. 2016 Oct 20;11(10):e0164811. doi: 10.1371/journal.pone.0164811. eCollection 2016.

2.
3.

Screening of natural compounds as activators of the keap1-nrf2 pathway.

Wu KC, McDonald PR, Liu J, Klaassen CD.

Planta Med. 2014 Jan;80(1):97-104. doi: 10.1055/s-0033-1351097. Epub 2013 Dec 5.

4.

Implementation of a high-throughput screen for identifying small molecules to activate the Keap1-Nrf2-ARE pathway.

Wu KC, McDonald PR, Liu JJ, Chaguturu R, Klaassen CD.

PLoS One. 2012;7(10):e44686. doi: 10.1371/journal.pone.0044686. Epub 2012 Oct 8.

5.

Alkylation sensitivity screens reveal a conserved cross-species functionome.

Svilar D, Dyavaiah M, Brown AR, Tang JB, Li J, McDonald PR, Shun TY, Braganza A, Wang XH, Maniar S, St Croix CM, Lazo JS, Pollack IF, Begley TJ, Sobol RW.

Mol Cancer Res. 2012 Dec;10(12):1580-96. doi: 10.1158/1541-7786.MCR-12-0168. Epub 2012 Oct 4.

6.

Compound ranking based on a new mathematical measure of effectiveness using time course data from cell-based assays.

Diaz FJ, McDonald PR, Roy A, Taylor B, Price A, Hall J, Blagg BS, Chaguturu R.

Comb Chem High Throughput Screen. 2013 Mar;16(3):168-79.

7.

First metatarsophalangeal joint arthrodesis.

Rajczy RM, McDonald PR, Shapiro HS, Boc SF.

Clin Podiatr Med Surg. 2012 Jan;29(1):41-9. doi: 10.1016/j.cpm.2011.11.001. Review.

PMID:
22243568
8.

Identification of chemosensitivity nodes for vinblastine through small interfering RNA high-throughput screens.

Kitchens CA, McDonald PR, Shun TY, Pollack IF, Lazo JS.

J Pharmacol Exp Ther. 2011 Dec;339(3):851-8. doi: 10.1124/jpet.111.184879. Epub 2011 Aug 31.

9.
10.
11.

The Shaping of the Face Space in Early Infancy: Becoming a Native Face Processor.

Slater A, Quinn PC, Kelly DJ, Lee K, Longmore CA, McDonald PR, Pascalis O.

Child Dev Perspect. 2010 Dec 1;4(3):205-211.

12.

Open access high throughput drug discovery in the public domain: a Mount Everest in the making.

Roy A, McDonald PR, Sittampalam S, Chaguturu R.

Curr Pharm Biotechnol. 2010 Nov;11(7):764-78. Review.

13.

Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic development.

Thaker NG, Zhang F, McDonald PR, Shun TY, Lazo JS, Pollack IF.

Neurosurg Focus. 2010 Jan;28(1):E4. doi: 10.3171/2009.10.FOCUS09210.

PMID:
20043719
14.

Identification of survival genes in human glioblastoma cells by small interfering RNA screening.

Thaker NG, Zhang F, McDonald PR, Shun TY, Lewen MD, Pollack IF, Lazo JS.

Mol Pharmacol. 2009 Dec;76(6):1246-55. doi: 10.1124/mol.109.058024. Epub 2009 Sep 25.

15.

Designing, optimizing, and implementing high-throughput siRNA genomic screening with glioma cells for the discovery of survival genes and novel drug targets.

Thaker NG, McDonald PR, Zhang F, Kitchens CA, Shun TY, Pollack IF, Lazo JS.

J Neurosci Methods. 2010 Jan 15;185(2):204-12. doi: 10.1016/j.jneumeth.2009.09.023. Epub 2009 Sep 25.

PMID:
19782703
16.

Synthetic protection short interfering RNA screen reveals glyburide as a novel radioprotector.

Jiang J, McDonald PR, Dixon TM, Franicola D, Zhang X, Nie S, Epperly LD, Huang Z, Kagan VE, Lazo JS, Epperly MW, Greenberger JS.

Radiat Res. 2009 Oct;172(4):414-22. doi: 10.1667/RR1674.1.

17.
18.

A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells.

Vogt A, McDonald PR, Tamewitz A, Sikorski RP, Wipf P, Skoko JJ 3rd, Lazo JS.

Mol Cancer Ther. 2008 Feb;7(2):330-40. doi: 10.1158/1535-7163.MCT-07-2165. Epub 2008 Feb 1.

19.

Integration of preoperative and intraoperative functional brain mapping in a frameless stereotactic environment for lesions near eloquent cortex. Technical note.

McDonald JD, Chong BW, Lewine JD, Jones G, Burr RB, McDonald PR, Koehler SB, Tsuruda J, Orrison WW, Heilbrun MP.

J Neurosurg. 1999 Mar;90(3):591-8.

PMID:
10067937
20.

Stereotactic interstitial brachytherapy of malignant astrocytomas with remarks on postimplantation computed tomographic appearance.

Willis BK, Heilbrun MP, Sapozink MD, McDonald PR.

Neurosurgery. 1988 Sep;23(3):348-54.

PMID:
3226513
21.

Brown-Roberts-Wells stereotactic frame modifications to accomplish magnetic resonance imaging guidance in three planes.

Heilbrun MP, Sunderland PM, McDonald PR, Wells TH Jr, Cosman E, Ganz E.

Appl Neurophysiol. 1987;50(1-6):143-52.

PMID:
3329837
22.
23.

Evolution of cataract surgery since the deSchweinitz era.

McDonald PR.

Ophthalmic Surg. 1979 May;10(5):44-52. No abstract available.

PMID:
384318
24.

Retinitis secondary to acquired systemic toxoplasmosis with isolation of the parasite.

Michelson JB, Shields JA, McDonald PR, Manko MA, Abraham AA, Federman JL.

Am J Ophthalmol. 1978 Oct;86(4):548-52.

PMID:
707602
25.

Ultrasonography and 32P test in diagnosis of malignant melanomas in eyes with hazy media.

Shields JA, McDonald PR, Leonard BC, Canny CL.

Trans Am Ophthalmol Soc. 1976;74:261-81. No abstract available.

26.

The diagnosis of uveal malignant melanomas in eyes with opaque media.

Shields JA, McDonald PR, Leonard BC, Canny CL.

Am J Ophthalmol. 1977 Jan;83(1):95-105.

PMID:
835673
27.

Obituary: Edmund Benjamin Spaeth, M.D. 1890-1976.

McDonald PR.

Am J Ophthalmol. 1976 Nov;82(5):801-2. No abstract available.

PMID:
793401
28.

Malignant melanoma arising in a choroidal magnacellular nevus (melanocytoma).

Barker-Griffith AE, McDonald PR, Green WR.

Can J Ophthalmol. 1976 Apr;11(2):140-6.

PMID:
1078332
29.

Intraocular microsurgery: I. New instrumentation (SITE).

Federman JL, Cook K, Bross R, Sarin LK, Tasman WS, Annesley WH, McDonald PR.

Ophthalmic Surg. 1976 Spring;7(1):82-7.

PMID:
1264423
30.

Malignant melanomas of the uveal tract in children and young adults.

Leonard BC, Shields JA, McDonald PR.

Can J Ophthalmol. 1975 Oct;10(4):441-9.

PMID:
1192263
31.

The patient as a person.

McDonald PR.

Trans Pa Acad Ophthalmol Otolaryngol. 1975 Fall;28(2):114-7. No abstract available.

PMID:
1189008
32.

Improvements in the diagnosis of posterior uveal melanomas.

Shields JA, McDonald PR.

Arch Ophthalmol. 1974 Apr;91(4):259-64. No abstract available.

PMID:
4621150
33.

Uveal pseudomelanoma due to posttraumatic pigmentary migration.

Shields JA, Green WR, McDonald PR.

Arch Ophthalmol. 1973 Jun;89(6):519-22. No abstract available.

PMID:
4706449
34.

Improvements in the diagnosis of posterior uveal melanomas.

Shields JA, McDonald PR.

Trans Am Ophthalmol Soc. 1973;71:193-210; discussions 210-1. No abstract available.

35.

Retinal detachment surgery--now and then.

McDonald PR.

Trans Pa Acad Ophthalmol Otolaryngol. 1972 Spring;25(1):9-20. No abstract available.

PMID:
4602508
36.

Treatment of intraretinal angiomas.

McDonald PR, Sarin LK.

Am J Ophthalmol. 1971 Jan;71(1 Pt 2):298-302. No abstract available.

PMID:
5100471
37.

The treatment of intraretinal angiomas.

McDonald PR, Sarin LK.

Trans Am Ophthalmol Soc. 1970;68:129-36. No abstract available.

38.

Changes in the posterior pole following successful reattachment of the retina.

Sarin LK, McDonald PR.

Trans Am Acad Ophthalmol Otolaryngol. 1970 Jan-Feb;74(1):75-9. No abstract available.

PMID:
5434999
39.

Oguchi's disease in Negroes.

Winn S, Tasman W, Spaeth G, McDonald PR, Justice J Jr.

Arch Ophthalmol. 1969 Apr;81(4):501-7. No abstract available.

PMID:
5305073
40.

Glaucoma complicated by cataract.

McDonald PR.

Trans Pa Acad Ophthalmol Otolaryngol. 1967 Spring;20(1):15-8. No abstract available.

PMID:
6045364
41.

Treatment of peripheral breaks: comparison of cryosurgery, diathermy, laser, and xenon photocoagulator.

McDonald PR, Tasman W.

Int Ophthalmol Clin. 1967 Summer;7(2):451-7. No abstract available.

PMID:
5601677
42.

NONRHEGMATOGENOUS RETINAL SEPARATION WITH CHOROIDAL DETACHMENT (UVEAL EFFUSION).

MCDONALD PR, DELAPAZ V Jr, SARIN LK.

Am J Ophthalmol. 1965 May;59:820-7. No abstract available.

PMID:
14288922
43.

REMOVAL OF DISLOCATED SOEMMERRING'S RING.

LAIBSON PR, MCDONALD PR.

Arch Ophthalmol. 1965 May;73:643-5. No abstract available.

PMID:
14281980
44.

SYMPOSIUM: PRESENT STATUS OF RETINAL DETACHMENT SURGERY.

MCDONALD PR, SARIN LK.

Trans Am Acad Ophthalmol Otolaryngol. 1964 Nov-Dec;68:998-1011. No abstract available.

PMID:
14237239
45.

NON-RHEGMATOGENOUS RETINAL SEPARATION ASSOCIATED WITH CHOROIDAL DETACHMENT.

MCDONALD PR, DELAPAZ V Jr, SARIN LK.

Trans Am Ophthalmol Soc. 1964;62:226-47. No abstract available.

46.

THE PROBLEM OF RETINAL DETACHMENT IN THE PRESENCE OF GLAUCOMA; PRESENTATION OF TWO CASES.

SARIN LK, CHESSEN GJ, MCDONALD PR.

Am J Ophthalmol. 1963 Dec;56:908-11. No abstract available.

PMID:
14088667
47.

Retinal holes in congenital glaucoma.

SARIN LK, TASSMAN WS, McDONALD PR.

Am J Ophthalmol. 1962 Feb;53:365-6. No abstract available.

PMID:
14497219
48.

Biography of Irving H. LEOPOLD, M. D.

MCDONALD PR.

Am J Ophthalmol. 1961 May;51:878-84. No abstract available.

PMID:
13773879
49.

Retinal detachment surgery.

MCDONALD PR.

Am J Ophthalmol. 1960 Dec;50:1247-51. No abstract available.

PMID:
13773880
50.

Changing concepts in retinal detachment surgery.

McDONALD PR.

Am J Ophthalmol. 1958 Jun;45(6):940-3. No abstract available.

PMID:
13533513

Supplemental Content

Loading ...
Support Center